Evidence-Based Medicine Guidelines
Cabergoline for levodopa-induced complications in Parkinson's disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Cabergoline for Levodopa-induced Complications in Parkinson's Disease." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/456850/all/Cabergoline_for_levodopa_induced_complications_in_Parkinson's_disease.
Cabergoline for levodopa-induced complications in Parkinson's disease. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. https://evidence.unboundmedicine.com/evidence/view/EBMG/456850/all/Cabergoline_for_levodopa_induced_complications_in_Parkinson's_disease. Accessed December 9, 2024.
Cabergoline for levodopa-induced complications in Parkinson's disease. (2024). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/456850/all/Cabergoline_for_levodopa_induced_complications_in_Parkinson's_disease
Cabergoline for Levodopa-induced Complications in Parkinson's Disease [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. [cited 2024 December 09]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/456850/all/Cabergoline_for_levodopa_induced_complications_in_Parkinson's_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Cabergoline for levodopa-induced complications in Parkinson's disease
ID - 456850
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/456850/all/Cabergoline_for_levodopa_induced_complications_in_Parkinson's_disease
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
